Cancer stem cell targeted therapy: progress amid controversies
-
- Tao Wang
- School of Nursing, Zhengzhou University, Zhengzhou, China
-
- Sarah Shigdar
- School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia
-
- Michael P. Gantier
- Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia
-
- Yingchun Hou
- Co-Innovation Center for Qinba Region's Sustainable Development, Shaanxi Normal University, Xi'an, China
-
- Li Wang
- Department of Gynecologic Oncology, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
-
- Yong Li
- Cancer Care Centre, St George Hospital and St George Clinical School, University of New South Wales (UNSW), Kensington, Australia
-
- Hadi Al Shamaileh
- School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia
-
- Wang Yin
- School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia
-
- Shu-Feng Zhou
- Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA
-
- Xinhan Zhao
- Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University School of Medicine, Xi'an, China
-
- Wei Duan
- School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia
Journal
-
- Oncotarget
-
Oncotarget 6 (42), 44191-44206, 2015-10-19
Impact Journals, LLC
- Tweet
Details 詳細情報について
-
- CRID
- 1360292620593101312
-
- ISSN
- 19492553
-
- Data Source
-
- Crossref